Better Therapeutics, Inc. (BTTX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -39.76 Million USD | 1.43% |
| 2021 | -40.33 Million USD | -531.52% |
| 2020 | -6.38 Million USD | -10.22% |
| 2019 | -5.79 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q3 | -5.86 Million USD | 22.76% |
| 2023 Q1 | -9.35 Million USD | -6.75% |
| 2023 Q2 | -7.58 Million USD | 18.89% |
| 2022 Q3 | -11.4 Million USD | -14.88% |
| 2022 Q2 | -9.92 Million USD | 0.51% |
| 2022 Q1 | -9.97 Million USD | 28.18% |
| 2022 FY | -39.76 Million USD | 1.43% |
| 2022 Q4 | -8.76 Million USD | 23.15% |
| 2021 FY | -40.33 Million USD | -531.52% |
| 2021 Q4 | -13.89 Million USD | -5714.75% |
| 2021 Q3 | -238.94 Thousand USD | 97.24% |
| 2021 Q2 | -8.65 Million USD | -62.29% |
| 2021 Q1 | -5.33 Million USD | -248965.42% |
| 2020 Q1 | -1782.00 USD | 0.0% |
| 2020 FY | -6.38 Million USD | -10.22% |
| 2020 Q4 | -2140.00 USD | 15.95% |
| 2020 Q3 | -2546.00 USD | 99.76% |
| 2020 Q2 | -1.05 Million USD | -59159.26% |
| 2019 FY | -5.79 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| America Great Health | -761.42 Thousand USD | -5121.822% |
| Ampio Pharmaceuticals, Inc. | -8.63 Million USD | -360.612% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -29.305% |
| Biora Therapeutics, Inc. | -124.11 Million USD | 67.965% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -147.294% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -110.749% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -116.346% |
| Gene Biotherapeutics, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -11.027% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -10.245% |
| Evelo Biosciences, Inc. | -114.52 Million USD | 65.283% |
| Evolutionary Genomics, Inc. | -2.24 Million USD | -1668.479% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | 46.812% |
| Galera Therapeutics, Inc. | -59.08 Million USD | 32.704% |
| Innovation1 Biotech Inc. | -5.98 Million USD | -563.965% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -86.719% |
| Molecular Templates, Inc. | -8.12 Million USD | -389.414% |
| Navidea Biopharmaceuticals, Inc. | -15.17 Million USD | -161.973% |
| NexImmune, Inc. | -32.34 Million USD | -22.927% |
| Orgenesis Inc. | -55.36 Million USD | 28.18% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -57.384% |
| Point of Care Nano-Technology, Inc. | -78.01 Thousand USD | -50863.252% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -117.39% |
| Scopus BioPharma Inc. | -11.6 Million USD | -242.468% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 93.059% |
| Statera Biopharma, Inc. | -174.4 Million USD | 77.203% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -1008.138% |
| Trevena, Inc. | -40.28 Million USD | 1.313% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -69735.248% |
| Vaccinex, Inc. | -20.25 Million USD | -96.336% |
| Vicapsys Life Sciences, Inc. | -1.18 Million USD | -3263.471% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | 22.128% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -411.239% |